Medicine and Dentistry
Chimeric Antigen Receptor T-Cell
100%
Biocompatible Material
100%
Ex Vivo
100%
T Cell
39%
Chimeric Antigen Receptor
25%
Health Care Cost
19%
Chimeric Antigen Receptor T-Cell Immunotherapy
15%
Virus Vector
15%
Disease
14%
Engraftment
10%
In Vitro
10%
Neoplasm
10%
Hexadimethrine Bromide
6%
Cell Therapy
5%
Solid Malignant Neoplasm
5%
Lymphocyte
5%
Peripheral Blood Mononuclear Cell
5%
Viral Gene Delivery System
5%
Graft Versus Host Reaction
5%
Cytokine
5%
Health Disparity
5%
Keyphrases
In Situ
75%
Cell Manufacturing
75%
Bioresorbable Scaffold
75%
Chimeric Antigen Receptor T Cells (CAR-T)
75%
T Cells
23%
Viral Vectors
11%
Allogeneic
10%
Unmet Needs
7%
Anti-CD3/CD28
5%
Naïve T Cells
5%
Automatic Manufacturing
5%
Centrifugation
5%
Polybrene
5%
Regulatory Burden
5%
RetroNectin
5%
Time Burden
5%
Therapy Costs
5%
Cell Engraftment
5%
Implanted Biomaterials
5%
Heterogeneous Composition
5%
Simultaneous Activation
5%
Single Patient
5%
Immunology and Microbiology
Chimeric Antigen Receptor T-Cell
100%
T Cell
35%
Chimeric Antigen Receptor
25%
Chimeric Antigen Receptor T-Cell Therapy
15%
Viral Vector
15%
CD3 Antigen
11%
CD28
10%
Monospecific Antibody
10%
Engraftment
10%
Naive T Cell
6%
Centrifugation
6%
Peripheral Blood Mononuclear Cell
6%
Lymphocyte
5%
Graft-Versus-Host Disease
5%
Cytokine
5%
Viral Gene Delivery System
5%
Health Disparity
5%